immunoadsorption

Preprint Link to published paper here ** The Lancet: Efficacy of Repeat Immunoadsorption in Post-COVID ME/CFS Patients with Elevated B2-Adrenergic Receptor Autoantibodies: A Prospective Cohort Study Abstract Background: Since the pandemic, SARS-CoV-2 has become the leading trigger for ME/CFS...

Scheibenbogen et al Abstract There is increasing evidence for an autoimmune aetiology in post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). SARS-CoV-2 has now become the main trigger for ME/CFS. We have already conducted two small proof-of-concept studies of IgG...

Immune adsorption for the treatment of fatigue-dominant long-/post-COVID syndrome—a case series of standardized individual experimental therapy Research letter / case series of 10 patients. Announced English version not published yet. So in lieu of an abstract here's a google translate link...

Slow reveal—the paper will be in German apparently—putting this here as place holder until they reveal the treatment in the next few days. I’m always skeptical of these slow reveal deals—might be scam-ish??

Repeat Immunoadsorption Post Covid ME/CFS https://clinicaltrials.gov/ct2/show/NCT05629988 From Dr. Carmen Scheibenbogen's team at Charite University. Their summary: It's an observational study with no control group, so not rigorous. But after this study they want to do an RCT.

https://www.mdpi.com/2077-0383/9/8/2443

Open access, https://onlinelibrary.wiley.com/doi/full/10.1002/ehf2.12633